NewsBenzingaAddex Therapeutics Q2 EPS $(1.52) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY Addex Therapeutics Q2 EPS $(1.52) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY Benzinga 2026.09.28 06:05 (GMT+0) Open on Benzinga Other news If Apple Cuts iPhone Units in 2027, This Stock Could Be a Big Loser Trust company AnchorWatch Trust Company launches Bitcoin custody service Wells Fargo Maintains Equal-Weight on PENN Entertainment, Lowers Price Target to $22 HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target Alphabet Stock Rises: What's Going On? $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
